跳至主要内容
临床试验/NCT06368479
NCT06368479已完成不适用

A Prospective Cross-Sectional Study to Evaluate Diagnostic Sensitivity and Specificity of iStatis HBsAg Test at the Point-Of-Care Site Settings

bioLytical Laboratories2 个研究点 分布在 1 个国家目标入组 1,400 人开始时间: 2024年3月19日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
1,400
试验地点
2
主要终点
iStatis Performance

研究概览

简要总结

A prospective cross-sectional study in which surgically non-invasive sample-taking is done only for the purpose of testing the samples on iStatis HBsAg Test at the point of care.

详细描述

Participants are prospctively recruited and enrolled to participate in the study. The Capillary (fingerstick) whole blood, and venous whole blood samples (in serum separating tube (SST) and Ethylenediaminetetraacetic acid (EDTA) tube) are collected by a healthcare professional. Serum and plasma samples will be extracted through laboratory processing of the collected serum separating tube and Ethylenediaminetetraacetic acid VWB, respectively. The collected samples of capillary will be tested on iStatis HBsAg Test. The collected Ethylenediaminetetraacetic acid and serum separating tube VWB will be shipped to the central laboratory to appropriately process and extract serum and plasma samples. Ethylenediaminetetraacetic acid VWB, plasma and serum will be tested on iStatis HBsAg Test in the laboratory. An aliquot of the obtained plasma sample will be further tested for reference and confirmatory testing.

The results from iStatis HBsAg Test results will not be used for participant management decisions.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Screening
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Participants/subjects (males, females, and pregnant women) getting tested for Hepatitis B virus for one or more of the following reasons:
  • at risk for Hepatitis B virus
  • having signs and symptoms indicative for Hepatitis B virus
  • Routine testing Unknown or other reasons will be captured
  • Participants/subjects of 18 years or older and, who are able to give/sign the informed consent.

排除标准

  • Participant younger than 18 years old
  • Participants unable to provide written informed consent

结局指标

主要结局

iStatis Performance

时间窗: 3 Months

To evaluate the device performance i.e. diagnostic sensitivity and diagnostic specificity of the iStatis Hepatitis B surface Antigen (HBsAg) Test compared to comparator assay.

次要结局

未报告次要终点

研究者

发起方
bioLytical Laboratories
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Diagnostic Sensitivity and Specificity of iStatis... | 临床试验